BCAA supplementation also reduced the risk for HCC in obese patients with liver cirrhosis [3], which demonstrates the clinical significance of lowering insulin levels and attenuating insulin resistance in the prevention of liver carcinogenesis in obese and diabetic patients. Here, INS is linked to hepatocellular carcinoma.